PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Ensysce Biosciences, Inc.
Filed: October 15, 2019
Period of Report: October 15, 2019
Accession Number: 0001213900-19-020378

View Document ↗ View on SEC.gov ↗